New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.
Berlin [Germany], December 29 (ANI/Sputnik): An female elderly worker at a German care home who was mistakenly injected with five times the recommended dose of the Pfizer/Biotech vaccine is still in the hospital, the Ostsee-Zeitung newspaper reported on Tuesday.
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on the Vice President M Venkaiah Naidu in Hyderabad on Friday.
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M Venkaiah Naidu at his residence on Friday in Hyderabad.
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
New Delhi [India], December 16 (ANI): No serious adverse effect related to the vaccine has been reported by COVID-19 vaccine (BBV152) COVAXIN, the interim finding from the phase 1 clinical trial of COVAXIN has stated which has now been published in the pre-print version on Monday.
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Gandhinagar (Gujarat) [India], December 16 (ANI/BusinessWire India): Led by Dr JM Vyas, Vice Chancellor, National Forensic Sciences University (NFSU) and Dr K Thangaraj, Director, Centre for DNA Fingerprinting & Diagnostics (CDFD), experts from the fields of forensics, biotechnology, law
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' has been referred to Medanta Hospital Gurugram on Tuesday.
Rohtak (Haryana) [India], December 14 (ANI): Haryana Home Minister Anil Vij, who had tested positive for coronavirus on December 5, was shifted to the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak from Ambala's civil hospital.